News

Ge

Nuffield Health signs £200 million agreement with GE HealthCare

Nuffield Health has signed a new 20-year agreement worth £200 million with medical technology company GE HealthCare to provide diagnostic services. This partnership is set to enhance diagnostic capabilities and, according to the UK’s largest healthcare charity, will help alleviate pressure on the NHS by addressing growing waiting lists. Currently, almost 20% of NHS diagnostic patients are waiting longer than the government’s six-week target.

“We are committed to playing our part in getting the nation back to better health. With NHS under sustained pressure and waiting lists at critical levels, this major investment will deliver cutting-edge diagnostic technology, helping to deliver faster, more accurate diagnoses, and opening up much-needed capacity to treat more people,” says Nuffield Health chief executive Alex Perry. 

The deal builds on a successful multi-vendor servicing agreement from 2017, where GE HealthCare managed Nuffield Health’s full portfolio of medical technology across its 37 hospitals and 110 fitness and wellbeing centers. Under this new 20-year managed service contract, GE HealthCare will oversee the acquisition, installation, maintenance, and training of medical technology used by Nuffield Health.

This year alone, more than 100 devices are set to be delivered across Nuffield Health’s network of hospitals, and nearly 800 pieces of equipment will be rolled out over the course of the partnership, covering areas like imaging, ultrasound, surgery, and X-ray.

The agreement mirrors a similar seven-year strategic partnership that GE HealthCare recently signed with Sutter Health in California.


© GE HealthCare
© Nuffield Health

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Relevance Ventures Leads Multimillion-Dollar Series B Financing for Aqua Medical to Advance Minimally Invasive Type 2 Diabetes Treatment

The Growth of the Medical Industry Amid Tariff Pressures and the Push to Reshore Manufacturing to the United States

Vent Creativity℠ Obtains FDA-Clearance for AI-Powered Digital-Twin Knee Arthroplasty Planning Tool, Hermes.

Johnson & Johnson MedTech Announces Approval of MONARCH™ QUEST for Enhanced Robotic-Assisted Bronchoscopy

Globus Medical obtains FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe